Dr. John B. Liao, MD

Dr. Liao practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Liao's NPI, 1730389057, was assigned on July 24, 2007. Dr. Liao graduated from George Washington University School of Medicine in 1998. Dr. Liao holds Pennsylvania license MT190066.

Dr. Liao's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Dr. Liao's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Liao is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liao practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Liao's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Liao is licensed in Pennsylvania.

CMS data shows 49 Medicare services from Dr. Liao across 2 procedure codes in 2024, for 42 Medicare patients. Medicare paid $2,102 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Liao in 2024. The largest group is 65 to 74, with 25 patients. 57% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liao's median patient age at 65, with 96% women.

In 2024, Dr. Liao wrote 14 Medicare Part D claims. 86% of them were for generic drugs. They cover 2 drugs, with $502 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Liao for performance year 2024, reported through an alternative payment model (APM). Dr. Liao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Liao as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Liao, published from 2010 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Cancer Vaccines and Genital Neoplasms, Female. Dr. Liao has published most often in Gynecol Oncol. Dr. Liao's most frequent co-authors are Barbara Ann Goff, Mary Lenora Disis and Renata Rose Urban, MD.

Dmand AI links Dr. Liao to 5 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Fallopian Tube Diseases and Fallopian Tube Neoplasms. University of Washington sponsors the most, 3.

CMS Open Payments shows 6 general payments to Dr. Liao from 3 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 83% of the total. Pacira Pharmaceuticals Incorporated paid the most, $121.

Dr. Liao graduated from George Washington University School of Medicine in 1998.